170 related articles for article (PubMed ID: 25376731)
1. Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
Liu B; Zhou W; Chen X; Xu F; Chen Y; Liu J; Zhang Q; Bao S; Chen N; Li M; Zhu R
Mol Med Rep; 2015 Mar; 11(3):1609-14. PubMed ID: 25376731
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.
Lu CJ; He YF; Yuan WZ; Xiang LJ; Zhang J; Liang YR; Duan J; He YH; Li MY
World J Gastroenterol; 2017 Sep; 23(34):6242-6251. PubMed ID: 28974890
[TBL] [Abstract][Full Text] [Related]
3. A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells.
Liu B; Tan X; Liang J; Wu S; Liu J; Zhang Q; Zhu R
Sci Rep; 2014 Nov; 4():7041. PubMed ID: 25391369
[TBL] [Abstract][Full Text] [Related]
4. Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells.
Huang X; Lian T; Guan X; Liu B; Hao S; Zhang J; Bao S; Tan X; Zhu R
Protein Pept Lett; 2017; 24(5):419-424. PubMed ID: 28240161
[TBL] [Abstract][Full Text] [Related]
5. Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells.
Ji FJ; Tian XF; Liu XW; Fu LB; Wu YY; Fang XD; Jin HY
Genet Mol Res; 2015 Dec; 14(4):15564-71. PubMed ID: 26634523
[TBL] [Abstract][Full Text] [Related]
6. IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.
Hubackova S; Kucerova A; Michlits G; Kyjacova L; Reinis M; Korolov O; Bartek J; Hodny Z
Oncogene; 2016 Mar; 35(10):1236-49. PubMed ID: 25982278
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.
Fan TF; Wu TF; Bu LL; Ma SR; Li YC; Mao L; Sun ZJ; Zhang WF
Oncotarget; 2016 Sep; 7(37):59691-59703. PubMed ID: 27474168
[TBL] [Abstract][Full Text] [Related]
8. Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells.
Liu B; Shi Y; Peng W; Zhang Q; Liu J; Chen N; Zhu R
Mol Med Rep; 2016 Jul; 14(1):159-64. PubMed ID: 27176768
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms.
Sancho P; Bertran E; Caja L; Carmona-Cuenca I; Murillo MM; Fabregat I
Biochim Biophys Acta; 2009 Feb; 1793(2):253-63. PubMed ID: 18848961
[TBL] [Abstract][Full Text] [Related]
10. Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells.
Zhou DZ; Sun HY; Yue JQ; Peng Y; Chen YM; Zhong ZJ
Free Radic Res; 2017 May; 51(5):517-528. PubMed ID: 28482716
[TBL] [Abstract][Full Text] [Related]
11. Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
Jiang L; Zhang Q; Ren H; Ma S; Lu C; Liu B; Liu J; Liang J; Li M; Zhu R
PLoS One; 2015; 10(4):e0124994. PubMed ID: 25915649
[TBL] [Abstract][Full Text] [Related]
12. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.
Crosas-Molist E; Bertran E; Sancho P; López-Luque J; Fernando J; Sánchez A; Fernández M; Navarro E; Fabregat I
Free Radic Biol Med; 2014 Apr; 69():338-47. PubMed ID: 24509161
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway.
Zhou MQ; Shao L; Wu J; Peng N; Jin LP; Wei GZ; Cheng W; Deng CJ
Mol Med Rep; 2017 Dec; 16(6):8983-8988. PubMed ID: 29039483
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
[TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
Xie J; Liu J; Chen TM; Lan Q; Zhang QY; Liu B; Dai D; Zhang WD; Hu LP; Zhu RZ
World J Gastroenterol; 2015 May; 21(18):5473-81. PubMed ID: 25987769
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
Jiang L; Ye WC; Li Z; Yang Y; Dai W; Li M
BMC Complement Med Ther; 2021 Jul; 21(1):194. PubMed ID: 34229692
[TBL] [Abstract][Full Text] [Related]
17. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
Huang H; Hu M; Zhao R; Li P; Li M
Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
[TBL] [Abstract][Full Text] [Related]
18. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.
Wu S; Liu B; Zhang Q; Liu J; Zhou W; Wang C; Li M; Bao S; Zhu R
PLoS One; 2013; 8(11):e76886. PubMed ID: 24223706
[TBL] [Abstract][Full Text] [Related]
19. Isoobtusilactone A-induced apoptosis in human hepatoma Hep G2 cells is mediated via increased NADPH oxidase-derived reactive oxygen species (ROS) production and the mitochondria-associated apoptotic mechanisms.
Chen CY; Liu TZ; Chen CH; Wu CC; Cheng JT; Yiin SJ; Shih MK; Wu MJ; Chern CL
Food Chem Toxicol; 2007 Jul; 45(7):1268-76. PubMed ID: 17321026
[TBL] [Abstract][Full Text] [Related]
20. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
